Trius Therapeutics Inc 4
4 · Trius Therapeutics Inc · Filed Jul 12, 2013
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-07-10$8.58/sh−1,000$8,580→ 176,860 total(indirect: By Trust) - Sale
Common Stock
2013-07-12$10.10/sh−5,000$50,500→ 171,360 total(indirect: By Trust) - Sale
Common Stock
2013-07-11$9.32/sh−500$4,660→ 176,360 total(indirect: By Trust)
Holdings
- 2,151
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012